COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022

Background: Epidemiologic studies on coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (pwMS) have focused on the first waves of the pandemic until early 2021. Objectives: We aimed to extend these data from the onset of the pandemic to the global coverage by vaccination in summ...

Full description

Bibliographic Details

Published in:	Multiple sclerosis 2024-03, Vol.30 (3), p.381-395
Main Authors:	Jeantin, Lina, Januel, Edouard, Labauge, Pierre, Maillart, Elisabeth, de Seze, Jérôme, Zéphir, Hélène, Pelletier, Jean, Kerschen, Philippe, Biotti, Damien, Heinzlef, Olivier, Guilloton, Laurent, Bensa, Caroline, Théaudin, Marie, Vukusic, Sandra, Casez, Olivier, Maurousset, Aude, Laplaud, David, Berger, Eric, Lebrun-Frenay, Christine, Bourre, Bertrand, Branger, Pierre, Stankoff, Bruno, Clavelou, Pierre, Thouvenot, Eric, Manchon, Eric, Moreau, Thibault, Sellal, François, Zedet, Mickaël, Papeix, Caroline, Louapre, Céline
Format:	Article
Language:	English
Subjects:	CD20 antigen Comorbidity Coronaviruses COVID-19 COVID-19 vaccines Epidemiology Human health and pathology Immunization Life Sciences Multiple sclerosis Multivariate analysis Neurological complications Pandemics Risk factors Vaccination
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!